Global Graves Disease Treatment Market 2019:Analysis By ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA & Others
The Graves disease treatment report endows with current and upcoming technical and financial details of the industry to 2025 and hence proves to be a valuable source of information. The report can be accessible to the users in the form of PDF or spreadsheet. Moreover, PPT format can also be offered depending upon client’s requirement. Further, the statistical and numerical data including facts and figures are characterized very properly with the help of charts, tables or graphs. The data and information cited in this Graves disease treatment report is very reliable as it is drawn only from the valuable and genuine resources.Global Graves disease treatment market is expected to grow at a steady CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the rise in number of patients with thyroid disorders, favorable reimbursement policies for treatment and increase in awareness about the complications associated with thyroid disorders and rising investment in the research & development of treatments for Hashimoto’s thyroiditis is expected to drive the market.
Key Market Players:
The key market players in the global Graves disease treatment market are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA, Amgen Inc, , Horizon Therapeutics plc, Medtronic, Immunovant, Inc, among others
Ask For Complimentary Sample PDF| Request At https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-graves-disease-treatment-market
Competitive Analysis:
Global Graves disease treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Graves disease treatment market for Global Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Drivers
High prevalence of autoimmune diseases such as Grave’s disease and Hashimoto’s thyroiditis is driving the market growth
Various national health programs related to thyroid disease that raise awareness regarding such diseases further boosts the growth of this market
Favorable reimbursement policies for the treatment
Increasing iodine disorder and thyroid tumors screening is also fueling the market growth
Market Restraints
High costs associated with the treatment and the usage of alternative medicines for the treatment of thyroid disorders is hindering the market growth
Side-effects associated with the current medication also restricts the market growth
Stringent government regulations is hampering the market growth
Table of Contents
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
View detailed table of content here https://www.databridgemarketresearch.com/toc/?dbmr=global-graves-disease-treatment-market
Segmentation: Global Graves Disease Treatment Market
By Mechanism of Action Type
Anti-thyroid Agents
Beta Blockers
Corticosteroids
Others
By Drugs
Propylthiouracil
Methimazole
Propranolol
Prednisone
Others
By Diagnosis
Physical Exam
Blood Test
Radioactive Iodine Uptake Test
Ultrasound
Imaging Tests
By Treatment
Medication
Radioactive Iodine Therapy
Surgery
Others
By Route of Administration
Oral
Intravenous
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By End-Users
Hospitals
Homecare
Specialty Clinics
Others
By Geography
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Key Developments in the Market
In June 2019, Horizon Therapeutics plc is developing teprotumumab, a complex protein that works by inhibiting the insulin-like growth factor I receptor (IGF-1R) for the treatment of Graves disease, currently ongoing in phase lll of OPTIC l trial. With this development the company provides better solution for the treatment of graves disease
In June 2019, Apitope is developing a novel drug ATX-GD-59, a peptide mixture of two different, highly soluble apitopes derived from TSH-receptor for the treatment of Graves disease currently ongoing in phase l clinical trial. If approved it will become the first innovative treatment in more than 60 years and will provide potential treatment to target the immunological basis of Graves’ disease
Inquiry For Customize Report With Discount at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-graves-disease-treatment-market
Reasons to Purchase this Report
Current and future of global Graves disease treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Graves Disease Treatment Market 2019:Analysis By ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, AbbVie Inc, Mylan N.V, Apitope, Merck KGaA & Others here
News-ID: 1852409 • Views: …
More Releases from Data Bridge Market Research
Siding Market to Observe Highest Growth of USD 154.27 million with an Excellent …
Global Siding Market Market study by Data Bridge Market Research provides details about the market dynamics affecting the Siding Market market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Siding Market market analysis report is the high quality report having in-depth market research studies.
For dominating the market or industry and making a mark in the…
Boric Acid Market Growth of USD 1,224.36 million with an Excellent CAGR of 4.1% …
Data Bridge Market research has recently released expansive research titled Global Boric Acid Market Market guarantees you will remain better informed than your competition.
Boric Acid Market Market report gives explanation about the different segments of the market analysis which is demanded by today's businesses. Key players are taking actions such as developments, product launches, acquisitions, mergers, joint ventures and competitive analysis in the industry. All the market aspects…
Peracetic Acid Market to Observe Prominent CAGR of 7.65% by 2028, Size, Share, T …
Peracetic Acid Market Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players…
Digital Inks Market to Observe Prominent CAGR of 8.34% by 2029, Size, Share, Tre …
Digital Inks Market Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and…
More Releases for Graves
Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in…
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/515950/graves-disease
Market…
US Graves' disease Market Growth, Share, Trends & Forecast to 2025
US Graves' disease market is growing at a CAGR of around 4.0% during the forecast period. The US Grave's disease market is showing significant growth due to funding for autoimmune disease researches, and the increasing prevalence of hyperthyroidism in the region. In addition, significant rise in the prevalence of autoimmune disease is also expected to propel the growth of the US Graves' disease market. According to the American Autoimmune Related…
Graves Diseases Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape.
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism) . Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment…
Global Clinical Trials Review for Graves Diseases, H2, 2017
"The Report Graves Diseases Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Graves Diseases Global Clinical Trials Review, H2, 2017
Summary
GlobalDatas clinical trial report, Graves Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Graves Diseases clinical trials scenario.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1335078
This report provides top line data relating to…
Graves disease Market: Positive long-term growth outlook 2017 - 2025
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S.
In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the…